시장보고서

상품코드

1419095

세계 기면증 치료제 시장 : 유형별, 제품별, 국가별, 지역별 산업 분석 - 시장 규모, 시장 점유율 및 예측(2023년-2030년)

Narcolepsy Therapeutics Market, By Type, By Product, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: 2024년 01월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 322 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

기면증 치료제 시장 규모는 2022년에 34억 3,000만 달러로 평가되었고, 2023년부터 2030년에 걸쳐 복합 연간 성장률(CAGR) 8.34%로 확대될 것으로 예측되고 있습니다.

기면증 치료제 시장 - 시장 역학

수면장애 유병률 증가, R&D 활동 및 투자 증가가 시장 수요 촉진

연구개발비와 활동 증가, 질병 유병률 상승, 혁신적인 의약품 출시는 시장 확대를 뒷받침하는 주요 요인의 일부입니다. 미국 국립신경질환·뇌졸중연구소(NINDS)의 추계에 의하면, 기면증는 미국에서 13만 5,000-20만명이 이환하고 있습니다. 향후 몇 년동안, 난콜렙시로 진단받는 사람의 수가 증가할 가능성이 높습니다. 예측 기간 동안 시장 확대를 촉진하는 요인 중 하나는 환자 수 증가입니다. National Organization for Rare Disorders에 따르면 약 2,000명 중 1명이 이 질환을 앓고 있습니다. 마찬가지로, 미국 미국 신경학회(American Academy of Neurology)의 조사에서 유병률은 인구 10만명당 20-60명으로 되어 있습니다.

시장이 확대되고 있는 이유는 질병 치료에 새로운 치료법을 도입하기 위한 연구개발(R&D)의 노력이 증가하고 있기 때문입니다. 최근 연구개발 활동의 가속화로 향후 몇년안에 새로운 치료법이 도입될 것으로 예상됩니다. 예를 들어, 2021년 5월, 다케다 약품공업 주식회사는 기면증 치료제의 연구개발을 발표했습니다.

기면증 치료제 시장 - 세분화 분석 :

세계 기면증 치료제 시장은 유형, 제품 및 지역에 따라 구분됩니다.

유형별로는 카타플렉시의 유무로 분류됩니다. 시장을 독점하는 것은 카타플렉시 부문입니다. 환자의 주요 증상으로 카타플렉시가 증가하고 있다는 것은 같은 부문의 성장을 뒷받침하고 있습니다.

시장은 제품에 따라 중추 신경계 자극제, 옥시베이트 나트륨, 삼환계 항우울제로 분류됩니다. 옥시베이트 나트륨은 시장을 독점하고 있으며 예측 기간 동안에도 우위를 유지할 것으로 보입니다. 특이한 신경질환 환자를 위한 중추신경자극제에 대한 연구개발 노력 증가가 이 부문의 성장을 가속할 것으로 예상됩니다.

기면증 치료제 시장 - 지리적 인사이트

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 의해 더 나뉩니다.

기면증 치료제 시장 - 경쟁 구도:

기면증 치료제 시장은 소수의 기업이 세계 시장을 독점하고 있으며, 그 특성상 단편화되지 않았습니다. 이 시장의 주요 기업은 급속한 투자와 M&A와 함께 신제품 설계에 주력하고 있습니다. 예를 들어(2022년) 5월, Axsome Therapeutics, Inc.는 미국 시장에서 Jazz Pharmaceuticals로부터 Sunosi를 획득했다고 발표했습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제10장 주요 벤더 분석 : 기면증 치료제 업계

경쟁 대시보드
기업 프로파일
- Teva Pharmaceutical Industries Ltd.
- Avadel Pharmaceuticals
- Jazz Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company
- Harmony Biosciences
- Novartis AG
- Rhodes Pharmaceuticals LP
- Axsome Therapeutics, Inc.
- Janssen Global Services, LLC
- Ligand Pharmaceuticals Incorporated
- Shionogi Inc.
- Eli Lilly and Company
- Others

제11장 애널리스트의 전방위 전망

BJH 24.02.13

REPORT HIGHLIGHT

Narcolepsy Therapeutics Market size was valued at USD 3,430 Million in 2022, expanding at a CAGR of 8.34% from 2023 to 2030.

A lifelong sleep illness that causes uncontrollably sudden episodes of extreme sleepiness called as narcolepsy which impacts all facets of a patient's life and makes daily tasks challenging. Narcolepsy can be treated symptomatically with medications that promote wakefulness and raise dopamine release at the presynaptic level.

Narcolepsy Therapeutics Market- Market Dynamics

Increasing prevalence of sleep disorder, increasing R&D activities & investments is to propel market demand

Increasing R&D expenditures and activities, rising disease prevalence, and the launch of innovative medicinal goods are some of the main causes propelling market expansion. Narcolepsy affects between 135,000 and 200,000 people in the United States, according to estimates from the National Institute of Neurological Disorders and Stroke (NINDS). In the upcoming years, there will likely be a rise in the number of people with narcolepsy diagnoses because the disease is more common in those who experience higher levels of stress. Over the forecast period, one of the key drivers propelling the market expansion is an increase in the patient base. As per the National Organization for Rare Disorders, around 1 in 2,000 individuals are affected with the condition. In a similar vein, the American Academy of Neurology study found that the prevalence of disease varies from 20 to 60 in 100,000 people.

The market is growing because of an increase in research and development (R&D) efforts to introduce novel therapeutic solutions for the treatment of disease. New treatment alternatives will be introduced in the upcoming years because of the recent acceleration of research and development activity. For example, in May 2021, Takeda Pharmaceutical Company Limited announced that research and development for narcolepsy medication.

Narcolepsy Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.34% over the forecast period (2023-2030)

Based on Type segmentation, cataplexy segment was predicted to show maximum market share in the year 2022, owing to its high adoption of novel drugs such as WAKIX, Xyrem, Xywav, etc.

Based on Product segmentation, sodium oxybate was the leading segment in 2022, mainly due to growing awareness levels pertaining to diagnosis.

On the basis of region, North America was the leading revenue generator in 2022. Asia Pacific expected to grow at the fastest CAGE over the forecast period.

Narcolepsy Therapeutics Market- Segmentation Analysis:

The Global Narcolepsy Therapeutics Market is segmented on the basis of Type, Product, and Region.

The market is divided into two categories based on Type: cataplexy and without cataplexy. The cataplexy segment dominates the market. The rise in a prevalence of cataplexy as a major symptom in patients is boosting the segment growth.

The market is divided into three categories based on Product: Central Nervous System Stimulants, Sodium Oxybate, and Tricyclic Antidepressants. The Sodium Oxybate segment dominates the market and is likely to maintain its dominance during the forecast period. It is anticipated that rising R&D efforts pertaining to CNS stimulants for patients with uncommon neurological illnesses will drive the segment's growth.

Narcolepsy Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Narcolepsy Therapeutics Market- Competitive Landscape:

The Narcolepsy Therapeutics market is less fragmented in nature with few players dominating global market. Key players in the market are focused on new product design paired with the rapid investment and mergers & acquisitions. For example, in May 2022, Axsome Therapeutics, Inc. announced the attainment of Sunosi from Jazz Pharmaceuticals across U.S. market.

Recent Developments:

In May 2023, Avadel Pharmaceuticals received final U.S. FDA approval for its drug Lumryz for the treatment of narcolepsy.

In January 2022, the U.S. FDA approved Orphan Drug Exclusivity for Jazz Pharmaceuticals' Xywav for the treatment of idiopathic hypersomnia in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NARCOLEPSY THERAPEUTICS MARKET KEY PLAYERS

Teva Pharmaceutical Industries Ltd.
Avadel Pharmaceuticals
Jazz Pharmaceuticals, Inc.
Takeda Pharmaceutical Company
Harmony Biosciences
Novartis AG
Rhodes Pharmaceuticals L.P.
Axsome Therapeutics, Inc.
Janssen Global Services, LLC
Ligand Pharmaceuticals Incorporated
Shionogi Inc.
Eli Lilly and Company
Others

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY TYPE

Cataplexy
Without Cataplexy

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY PRODUCT

Central Nervous System Stimulants
Sodium Oxybate
Tricyclic Antidepressants

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Narcolepsy Therapeutics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Narcolepsy Therapeutics Market Snippet by Type
- 2.1.2. Narcolepsy Therapeutics Market Snippet by Product
- 2.1.3. Narcolepsy Therapeutics Market Snippet by Country
- 2.1.4. Narcolepsy Therapeutics Market Snippet by Region
2.2. Competitive Insights

3. Narcolepsy Therapeutics Key Market Trends

3.1. Narcolepsy Therapeutics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Narcolepsy Therapeutics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Narcolepsy Therapeutics Market Opportunities
3.4. Narcolepsy Therapeutics Market Future Trends

4. Narcolepsy Therapeutics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Narcolepsy Therapeutics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Narcolepsy Therapeutics Market Landscape

6.1. Narcolepsy Therapeutics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Narcolepsy Therapeutics Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
- 7.1.2. Cataplexy
- 7.1.3. Without Cataplexy

8. Narcolepsy Therapeutics Market - By Product

8.1. Overview
- 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
- 8.1.2. Central Nervous System Stimulants
- 8.1.3. Sodium Oxybate
- 8.1.4. Tricyclic Antidepressants.

9. Narcolepsy Therapeutics Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Narcolepsy Therapeutics Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Narcolepsy Therapeutics Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.7.5. Overview
  - 9.3.7.6. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.7.7. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.7.8. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.8. France
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.8.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.8.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.8.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.9. Russia
  - 9.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.9.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.9.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.10. Netherlands
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.10.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.10.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.10.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.11. Sweden
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.11.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.11.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.3.12. Poland
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.12.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.12.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.12.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.13. Rest of Europe
  - 9.3.13.1. Overview
  - 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.3.13.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.3.13.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.3.13.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Narcolepsy Therapeutics Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.6.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.7.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.8.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.9.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.10.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.11.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.12.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.13.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.4.14.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Narcolepsy Therapeutics Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.6.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.7.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.8.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.9.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.5.10.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Narcolepsy Therapeutics Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.6.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.7.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.8.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.9.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.10.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.11.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  - 9.6.12.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Narcolepsy Therapeutics Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Teva Pharmaceutical Industries Ltd.
- 10.2.2. Avadel Pharmaceuticals
- 10.2.3. Jazz Pharmaceuticals, Inc.
- 10.2.4. Takeda Pharmaceutical Company
- 10.2.5. Harmony Biosciences
- 10.2.6. Novartis AG
- 10.2.7. Rhodes Pharmaceuticals L.P.
- 10.2.8. Axsome Therapeutics, Inc.
- 10.2.9. Janssen Global Services, LLC
- 10.2.10. Ligand Pharmaceuticals Incorporated
- 10.2.11. Shionogi Inc.
- 10.2.12. Eli Lilly and Company
- 10.2.13. Others

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us